Stock DPHARMA DUOPHARMA BIOTECH
Add to a list
To use this feature you must be a member
Log inSign up

All News Duopharma Biotech

Equities

DPHARMA

MYL7148OO009

End-of-day quote BURSA MALAYSIA
Other stock markets
 18:00:00 2024-06-09 EDT 		5-day change 1st Jan Change
1.28 MYR +2.40% Intraday chart for Duopharma Biotech +6.67% +1.59%
06-06 Duopharma Biotech Berhad Appoints Datuk Nik Moustpha Bin Haji Nik Hassan as Independent and Non-Executive Member of Risk Committee, Date of Change 7 June 2024 CI
06-06 Duopharma Biotech Berhad Announces Resignation of Datin Paduka Kartini Binti Hj Abdul Manaf as Independent and Non-Executive Member of Risk Committee, Date of Change 7 June 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Duopharma Biotech Berhad Appoints Datuk Nik Moustpha Bin Haji Nik Hassan as Independent and Non-Executive Member of Risk Committee, Date of Change 7 June 2024
CI
Duopharma Biotech Berhad Announces Resignation of Datin Paduka Kartini Binti Hj Abdul Manaf as Independent and Non-Executive Member of Risk Committee, Date of Change 7 June 2024
CI
Duopharma Biotech Berhad Announces Retirement of Tan Sri, Datin Paduka Siti Sa'diah Binti Sh Bakir as Non-Independent and Non-Executive Chairman
CI
Duopharma Biotech Berhad Appoints Puan Nik Fazila Binti Nik Mohamed Shihabuddin as Independent and Non-Executive Director, Date of Change 7 June 2024
CI
Duopharma Biotech Berhad Announces Re-Designation of Datin Paduka Kartini Binti Hj Abdul Manaf, Independent Director as Non-Independent and Non-Executive Chairman, Date of Change 7 June 2024
CI
Duopharma Biotech Berhad Appoints Puan Nik Fazila Binti Nik Mohamed Shihabuddin as Independent and Non-Executive Member of Audit Committee, Date of Change 7 June 2024
CI
Duopharma Biotech Berhad Announces Resignation of Datuk Nik Moustpha Bin Haji Nik Hassan as Independent and Non-Executive Member of Audit Committee, Date of Change 7 June 2024
CI
Duopharma’s Attributable Income Shrinks in Q1; Shares Down 2%
MT
Duopharma Biotech Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Duopharma Biotech Clinches MYR578 million Supply Deals
MT
Duopharma Biotech Berhad Announces the Appointment of Mohd Haris Bin Mohd Arshad as Non Independent and Non Executive Member of Nomination and Remuneration Committee
CI
Duopharma Biotech Berhad Appoints Mohd Haris Bin Mohd Arshad as Non-Independent and Non-Executive Director
CI
Duopharma Biotech Berhad Announces the Resignation of Amizar Binti Mizuar as Non Independent and Non Executive Member of Nomination and Remuneration Committee
CI
Duopharma Biotech Berhad Announces the Resignation of Puan Amizar Binti Mizuar as Non Independent and Non Executive Director
CI
Duopharma Biotech Berhad Announces the Cessation of Encik Muhammad Shukri Bin Ismail as Non Independent and Non Executive Alternate Director
CI
Duopharma Biotech's Profit Plummets in Q4 2023
MT
Duopharma Biotech Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Duopharma Biotech Berhad Announces Second Interim Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 21 March 2024
CI
Duopharma Biotech Issues Further Islamic Debt Worth MYR29 Million
MT
Duopharma Biotech Berhad Makes a Further Sukuk Wakalah Issuance of RMB 29.0 Million Under the Sukuk Wakalah Programme
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DPHARMA Stock
  4. News Duopharma Biotech